Transcriptomic decoding of dynamic brain activity alterations in chronic non-specific low back pain
Listen to this summary
This study investigates the dynamic alterations in brain activity associated with chronic non-specific low back pain (CNLBP) and their relationship with regional gene expression profiles. Using resting-state functional MRI and a hidden Markov model, the authors identified distinct neural activity patterns in CNLBP patients compared to healthy controls, revealing significant changes in brain dynamics and their correlation with gene expression linked to nociceptive and inflammatory pathways. The findings enhance the understanding of the neural mechanisms underlying CNLBP and suggest a connection between altered brain activity and genetic factors.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Regional anesthesia and pain medicine
View all →Jun 23, 2026 · Regional anesthesia and pain medicine
Impact of continuous serratus plane analgesia on quality of recovery after video-assisted thoracic surgery: a prospective double-blind, randomized, placebo-controlled trial
Jun 11, 2026 · Regional anesthesia and pain medicine
Novel ultrasound-guided rotator cuff interval injection using the biceps long-axis approach: a cadaveric study
Jun 10, 2026 · Regional anesthesia and pain medicine
National patterns and variation in regional anesthesia use for shoulder, hip, knee, and ankle arthroplasty: a National Inpatient Sample analysis
More in Anesthesiology
View all →Jun 24, 2026 · Journal of addiction medicine
Trends in Public Opinion About US Illicit Drug Policy: Results From the 2000 to 2025 Gallup Survey
Jun 24, 2026 · Journal of addiction medicine
Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant
Jun 24, 2026 · Critical care medicine
Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · Journal of addiction medicine
Medicaid Prior Authorization and Discontinuation of Buprenorphine
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


